In this issue:
- Self-administered intranasal etripamil for paroxysmal SVT
- Vitamin D supplementation does not have cardioprotective effects
- Barriers to prescribing PCSK9 inhibitors after coronary revascularisation
- Ferric carboxymaltose in patients with HF and iron deficiency
- Semaglutide in patients with obesity-related HFpEF
- Are anticoagulants justified in patients with atrial high-rate episodes?
- Should frail elderly patients who are taking warfarin be switched to a NOAC?
- Phase 1 trial of muvalaplin, an oral small molecule inhibitor of lipoprotein(a) formation
- Catheter ablation vs medical therapy for AF in end-stage HF
- Multivessel immediate vs staged revascularisation in acute STEMI
Download the Cardiology Research Review Issue 156 with commentary by A/Prof John Amerena (pdf) here








